- Home
- PALI vs CHMG Comparison
PALI vs CHMG Comparison
Compare PALI & CHMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PALI | CHMG |
|---|---|---|
| Founded | 1996 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.2M | 260.2M |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PALI | CHMG |
|---|---|---|
| Price | $1.63 | $55.42 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | $13.00 | ★ $57.00 |
| AVG Volume (30 Days) | ★ 3.0M | 5.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.46% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.53 |
| Revenue | ★ $260,000.00 | N/A |
| Revenue This Year | N/A | $37.32 |
| Revenue Next Year | N/A | $9.13 |
| P/E Ratio | ★ N/A | $36.18 |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $0.55 | $40.71 |
| 52 Week High | $2.64 | $65.50 |
Technical Indicators
Market Signals| Indicator | PALI | CHMG |
|---|---|---|
| Relative Strength Index (RSI) | 43.63 | 35.86 |
| Support Level | $1.57 | $53.83 |
| Resistance Level | $1.93 | $54.77 |
| Average True Range (ATR) | 0.11 | 1.20 |
| MACD | -0.00 | -0.56 |
| Stochastic Oscillator | 16.22 | 0.00 |
Price Performance
Historical ComparisonAbout PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
About CHMG Chemung Financial Corp
Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.